Despite sometimes lingering and understandable frustration with the time, expense and challenge of clinical trial patient recruitment, it is worth pausing to take stock of the evolution and progress that has been achieved — and recognize how far the industry has come collectively.

Part of the challenge is that with the evolution of protocol design, precision-medicine science and rare-disease targeting, sponsors attempt to recruit smaller groups of people from smaller pools of potential participants, increasing the degree of difficulty. But while patient recruitment remains difficult, the industry’s knowledge, sensitivity and agility have improved dramatically — and we see a progression from a vision of participant homogeneity, passivity and hesitance to one of participant heterogeneity, agency and interest. This playbook explores: 

• How the nature of clinical research has changed over the past four to five decades
• The shifts in patients’ perceptions of clinical trial participation
• The evolution of sponsors’ motives and viewpoints on patient recruitment 

Download the playbook to learn more about the drivers impacting recent shifts in clinical trial recruitment strategy — and how today's sponsors can leverage both historical and current insights to maximize value when collaborating with recruitment partners.